Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
2
×
san francisco top stories
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alphabet
alzheimer's
ameet nathwani
arches
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of harvard and mit
brook byers
charles chu
crispr
crispr cas14
david schenkein
deals
debate
decheng capital
detroit blog main
detroit top stories
diagnostic
digital
donald trump
drug price
econmoic impact
elimination
fda
food and drug administartion
georgia
glioblastoma
What
based
2
×
bio
2
×
american
available
best
big
biosciences
cas
cheaper
continue
crash
crispr
debate
develop
diagnostics
expects
faster
healthcare
industry
kind
mammoth
nash
people
pharmaceutical
policy
politicians
pressure
roundup
scalps
set
things
tiny
today
trump’s
u.s
what’s
Language
unset
Current search:
based
×
biotech
×
" san francisco blog main "
×
bio
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More